Drug profile · INN
monoctanoin
MOCTANIN
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
monoctanoin (MOCTANIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: perfusion, biliary. Current US regulatory status: approved.
Key facts
INN monoctanoin
Brand MOCTANIN
Route PERFUSION, BILIARY
Formulation LIQUID
Frequently asked questions
What is monoctanoin?
monoctanoin (MOCTANIN) is an FDA-listed pharmaceutical active ingredient. Route of administration: perfusion, biliary. Current US regulatory status: approved.
What is the brand name for monoctanoin?
MOCTANIN is a marketed brand name for monoctanoin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of monoctanoin?
monoctanoin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.